{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:00:29Z","timestamp":1773270029717,"version":"3.50.1"},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2006]]},"DOI":"10.2169\/internalmedicine.45.1720","type":"journal-article","created":{"date-parts":[[2006,10,16]],"date-time":"2006-10-16T21:33:15Z","timestamp":1161034395000},"page":"1049-1053","source":"Crossref","is-referenced-by-count":13,"title":["Acute Cerebral Infarction during Combination Chemotherapy with S-1 and Cisplatin for a Young Patient with a Mucin-Producing Adenocarcinoma of the Stomach"],"prefix":"10.2169","volume":"45","author":[{"given":"Shinya","family":"Ohashi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tazuke-Kofukai Medical Research Institute and Kitano Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujiro","family":"Yazumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Asada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tazuke-Kofukai Medical Research Institute and Kitano Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Walsh-McMonagle D, Green D. Low-molecular-weight heparin in the management of Trousseau's syndrome. Cancer 80: 649-655, 1997.","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<649::AID-CNCR1>3.3.CO;2-F"},{"key":"2","unstructured":"2. Trousseau A. Phlegmasia alba dolens in Clinique Medicale de L'Hotel-Dieu de Paris. New Sydenham Society, London, 282332, 1865."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112: 853-862, 2003.","DOI":"10.1172\/JCI200318882"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kooiker JC, MacLean JM, Sumi SM. Cerebral embolism, marantic endocarditis, and cancer. Arch Neurol 33: 260-264, 1976.","DOI":"10.1001\/archneur.1976.00500040044006"},{"key":"5","unstructured":"5. Pineo GF, Regoeczi E, Hatton MW, Brain MC. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med 82: 255-266, 1973."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pineo GF, Brain MC, Gallus AS, Hirsh J, Hatton MW, Regoeczi E. Tumors, mucus production, and hypercoagulability. Ann N Y Acad Sci 230: 262-270, 1974.","DOI":"10.1111\/j.1749-6632.1974.tb14458.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Doll DC, Ringenberg QS, Yarbro JW. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 4: 1405-1417, 1986.","DOI":"10.1200\/JCO.1986.4.9.1405"},{"key":"8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000225759","volume":"40","year":"1983","unstructured":"8. Goldhirsch A, Joss R, Markwalder TM, Studer H, Brunner K. Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone. Oncology 40: 344-345, 1983.","journal-title":"Oncology","ISSN":"https:\/\/id.crossref.org\/issn\/0030-2414","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Russmann S, Winkler A, Lovblad KO, Stanga Z, Bassetti C. Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation. Eur Neurol 48: 178-180, 2002.","DOI":"10.1159\/000065511"},{"key":"10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.51.3.899","volume":"51","year":"1998","unstructured":"10. El Amrani M, Heinzlef O, Debroucker T, Roullet E, Bousser MG, Amarenco P. Brain infarction following 5-fluorouracil and cisplatin therapy. Neurology 51: 899-901, 1998.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gamble GE, Tyrrell P. Acute stroke following cisplatin therapy. Clin Oncol (R Coll Radiol) 10: 274-275, 1998.","DOI":"10.1016\/S0936-6555(98)80022-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gerl A. Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 5: 607-614, 1994.","DOI":"10.1097\/00001813-199412000-00001"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Icli F, Karaoguz H, Dincol D, Demirkazik A, Gunel N, Karaoguz R, Uner A. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 72: 587-593, 1993.","DOI":"10.1002\/1097-0142(19930715)72:2<587::AID-CNCR2820720242>3.0.CO;2-V"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Serrano-Castro PJ, Guardado-Santervas P, Olivares-Romero J. Ischemic stroke following cisplatin and 5-fluorouracil therapy: a transcranial Doppler study. Eur Neurol 44: 63-64, 2000.","DOI":"10.1159\/000008197"},{"key":"15","unstructured":"15. Sobin LHWittekind C. TNM Classification of malignant tumours. 5th edition. New York, John Wiley &amp; Sons, 1997."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Koizumi W, Tanabe S, Saigenji K et al. Phase I\/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89: 2207-2212, 2003.","DOI":"10.1038\/sj.bjc.6601413"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 11: 237-248, 1992.","DOI":"10.1007\/BF01307180"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Russmann S, Winkler A, Lovblad KO, Stanga Z, Bassetti C. Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation. Eur Neurol 48: 178-180, 2002.","DOI":"10.1159\/000065511"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ito H, Okafuji T, Suzuki T. Vitamin E prevents endothelial injury associated with cisplatin injection into the superior mesenteric artery of rats. Heart Vessels 10: 178-184, 1995.","DOI":"10.1007\/BF01744983"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 314: 488-500, 1986.","DOI":"10.1056\/NEJM198602203140806"},{"key":"21","unstructured":"21. Willerson JT. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. Tex Heart Inst J 22: 13-19, 1995."},{"key":"22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/WNL.39.4.522","volume":"39","year":"1989","unstructured":"22. Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology 39: 522-526, 1989.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pinzon R, Drewinko B, Trujillo JM, Guinee V, Giacco G. Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center. J Clin Oncol 4: 509-514, 1986.","DOI":"10.1200\/JCO.1986.4.4.509"},{"key":"24","unstructured":"24. Taher A, Shamsseddine A, Saghir N et al. Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report. Eur J Gynaecol Oncol 20: 323-324, 1999."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42: 296-300, 1985.","DOI":"10.1159\/000226049"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 65: 885-889, 1990.","DOI":"10.1002\/1097-0142(19900215)65:4<885::AID-CNCR2820650410>3.0.CO;2-H"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Vogelzang NJ, Torkelson JL, Kennedy BJ. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer 56: 2765-2770, 1985.","DOI":"10.1002\/1097-0142(19851215)56:12<2765::AID-CNCR2820561208>3.0.CO;2-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Schilsky RL, Anderson T. Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med 90: 929-931, 1979.","DOI":"10.7326\/0003-4819-90-6-929"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Baba H, Yamamoto M, Endo K et al. Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. Gastric Cancer 6 Suppl 1: 45-49, 2003.","DOI":"10.1007\/s10120-003-0222-y"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Iwahashi M, Nakamori M, Tani M et al. Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case. Oncology 61: 16-22, 2001.","DOI":"10.1159\/000055347"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lee AY, Levine MN, Baker RI et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146-153, 2003.","DOI":"10.1056\/NEJMoa025313"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/45\/18\/45_18_1049\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T21:08:12Z","timestamp":1555880892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/45\/18\/45_18_1049\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":31,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.45.1720","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}